Delaying treatment of ocular hypertension: the ocular hypertension treatment study. - Wikidata - awgldk - TriplyDB

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

http://www.wikidata.org/entity/Q37663860

about

Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma Soluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucoma Nonlinear, multilevel mixed-effects approach for modeling longitudinal standard automated perimetry data in glaucoma Reducing variability in visual field assessment for glaucoma through filtering that combines structural and functional information.Cup size predicts subsequent functional change in early glaucoma Glaucoma: genes, phenotypes, and new directions for therapy.The effect of test variability on the structure-function relationship in early glaucoma.Factors predicting the rate of functional progression in early and suspected glaucoma Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma.Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study.Clinical options for the reduction of elevated intraocular pressure Assessment of linear-scale indices for perimetry in terms of progression in early glaucoma Why Do People (Still) Go Blind from Glaucoma?The rate of visual field change in the ocular hypertension treatment study.Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.Twenty-four-hour pattern of intraocular pressure in untreated patients with ocular hypertension.Series length used during trend analysis affects sensitivity to changes in progression rate in the ocular hypertension treatment study Seasonal changes in visual field sensitivity and intraocular pressure in the ocular hypertension treatment study.In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).Optical Quality and Related Factors in Ocular Hypertension: Preliminary Study Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.An hypothesis on pressure transmission from anterior chamber to optic nerve Detection and diagnosis of glaucoma: ocular imaging.Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review.Overview of the [corrected] travoprost /timolol BAK-free fixed combination.Latanoprost/timolol fixed combination for the treatment of glaucoma.Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.Perimetric indices as predictors of future glaucomatous functional change.Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective.Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study.Biomarkers of primary open-angle glaucoma.A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma.Sustained intraocular pressure reduction throughout the day with travoprost ophthalmic solution 0.004%.[Differentiation of ocular hypertension].One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.[Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].Effect of Hemifacial Spasm on Intraocular Pressure Measurement.

P2860

Q26861763-2A23FA6A-E1C1-4B54-82E5-D7B916B7BCF8 Q27331498-5EA0D8EC-EEF6-4A75-BB09-78A9B146BCD2 Q30653907-D62CD6B1-0B61-449A-8D98-D083026E6717 Q33957323-C7548EB7-ABA8-4D24-A219-3C3FE0B9A0DB Q34017451-1433B7E8-AF1F-453A-B1F1-F49E9FA9696F Q34090204-40E8B588-9869-4FD3-B22E-C68A2EE13CAB Q34242957-CB627184-C3C0-43DD-90B7-2E2EC45B3E01 Q34262878-AA34DCB4-4B84-4967-918A-0F8284E0757E Q34409191-BE1564E0-3A72-4D00-9191-AD30A86F14F2 Q34452693-A8C9E13F-82EE-498A-AAB0-4856CE577D5E Q34708267-8933B637-D943-4077-A4FB-60943335E1E6 Q35154160-A742A570-983A-4CFA-8D92-98E0FA1068E4 Q35160642-49C03E36-186D-40D9-A9F2-B514B81C6EBE Q35797177-275EF7F9-F98A-4D9E-9423-03F6BBB2EE96 Q35929958-99D7945C-8751-40D4-BD93-85498965A9C0 Q36354205-E6CD525F-DA1C-43D3-8F64-13FBD986D4C9 Q36571702-E7E75575-CCD6-4C1A-9D05-C69404E9DAF0 Q36683623-A3F09FEE-D0DA-49E5-B4DA-E709B1CB6ABB Q36745634-BF4CF30C-8B8D-4D4D-8A43-A1B2B9255D8B Q36898923-6030902C-B03F-44E3-9A7C-D2DD5A20B56C Q36936740-1DECF370-3AFA-4A61-BE6C-4F601140C066 Q36968248-D04E2E18-C32B-4490-A002-E7F14A88D008 Q37019335-DD5DC46F-F79F-4E0D-A54D-AFC82DAA6F3A Q37691829-2FFDC15C-882F-42F0-B483-474857762C73 Q37831356-03C24F85-2D44-4F5C-8DAF-D96E20794F42 Q37987586-16B0D144-B1A7-4C6D-AC4D-4DC99B227DBD Q38117401-FFEE55AD-F2AC-4C1C-B718-A13663303884 Q38988955-6C4B74AE-E9F7-4AFA-9FDA-396081162BE0 Q39207696-BC65BE6E-4972-467D-83EB-B4E86B231F90 Q39825144-7EBB8F60-8BB8-44BD-93F3-B812094F6ABC Q40219288-2E2368F6-70DD-4BEB-BC23-B75F93C50DB4 Q40552970-4A284566-A806-4231-8C74-57A61FEC9641 Q41489091-A178508B-5E12-4D92-981A-050DAAFC5190 Q41499379-9FDF4CCA-53E6-464D-842B-4A74B568251C Q41882390-CC2FEA71-3FF9-4E06-91BD-23A01DC572E5 Q42132152-67290C30-0C40-4261-B797-AB6C2066693B Q53067734-33F80C13-9FBE-4B8B-ADB6-C2128EDB1A09 Q54248457-03705EBA-000E-4D6D-A2DC-91D6A25792D4 Q54441843-EC9D0A96-66F9-434D-8694-2CDA2129AEEF Q55025550-27C2C42C-99F2-44D2-AF32-B8D158A86792

P2860

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

http://www.wikidata.org/entity/Q37663860

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@en

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@nl

type

label

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@en

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@nl

prefLabel

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@en

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@nl

P1433

Q37663860-29207BA9-396A-4741-841D-D6FB5EE775A3

P1476

Q37663860-3A231A07-A3B2-4C4D-A51D-57389A8FAA48

P2093

Q37663860-3296D07D-8D7A-4068-8DC5-4A8D0104A872

Q37663860-5796011C-A0A5-4050-9EBA-8F87D7A3F388

Q37663860-930E65AA-E369-4BE4-A956-6DAA2A34ADF1

Q37663860-C09E6C4D-7B4E-4382-B5CA-7999EEE1A94F

Q37663860-DD47F02B-CF3D-4992-AEF3-D3087D7D944E

Q37663860-E5B18BAC-1EAF-4CBF-9242-1FD7ACE73D7C

Q37663860-FA72E101-0F4F-4BB3-808D-9BAE3995A020

P2860

Q37663860-0FE2D46D-F660-4B82-AEE6-F031E621F510

Q37663860-153A2EAB-2CB9-47F6-AEF2-AF23FA500560

Q37663860-276222AB-2851-47D2-BFB4-DDAC21F67B13

Q37663860-3176A67E-7200-44A7-AD99-D4BB0534682B

Q37663860-41F550CF-1F7C-4AFA-AE60-DC6E8A988B83

Q37663860-5AF0367A-6E14-4129-9704-BD609ECDF1B9

Q37663860-5D0ED547-3133-454C-98EA-C8D5BCCFF6A0

Q37663860-65C2AB48-85A3-4FBA-89B4-C64BF6C9E7A7

Q37663860-6D7149B2-0BD9-4C83-BD3F-3F4D8D311D7E

Q37663860-759B06D1-1BC0-4C67-A8F6-C1D0BBC832FB

P304

Q37663860-42EEAEDD-970D-419B-BA38-40CCD9C24D79

P31

Q37663860-A1EB2B57-98BD-4F28-9245-31365FDD8CC0

P356

Q37663860-2F473F59-600E-4521-9260-7F64C6A44CA1

P407

Q37663860-3EDA881F-FE4C-497C-AD89-8FBB4E175445

P433

Q37663860-87F36D04-E295-4CD5-8CF4-1EDB5C0DFCF9

P478

Q37663860-6E85F0D0-E75B-499B-ADE9-15DA1E7B01BE

P50

Q37663860-0BAC714F-EFBB-4703-8A63-877E97BA7160

Q37663860-68E70696-652E-4FF0-84D3-59A6D3D83FBE

Q37663860-7AF1CD79-A962-441C-A7E5-5CA94C24D51A

Q37663860-8AB63F8F-42C9-436B-92F9-D25A9C67F9C6

P577

Q37663860-7D5E8B6E-5AB1-44F3-96DA-588A3D560363

P5875

Q37663860-8E15B261-2296-4801-A90D-54AD8FF04819

P698

Q37663860-E1C48A68-E5D7-42D4-9E6A-2D48BF1C4047

P921

Q37663860-96FC8D23-52B9-4CD9-8B19-72768DBE9045

P932

Q37663860-F1FC9A33-C8E5-4D14-B7A4-0F7A35986933

P356

ARCHOPHTHALMOL.2010.20

P1433

JAMA Ophthalmology

P1476

Delaying treatment of ocular hypertension: the ocular hypertension treatment study.

@en

P2093

Dale K Heuer

http://www.w3.org/2001/XMLSchema#string

Eve J Higginbotham

http://www.w3.org/2001/XMLSchema#string

John K Keltner

http://www.w3.org/2001/XMLSchema#string

M Roy Wilson

http://www.w3.org/2001/XMLSchema#string

Mae O Gordon

http://www.w3.org/2001/XMLSchema#string

Ocular Hypertension Treatment Study Group

http://www.w3.org/2001/XMLSchema#string

Richard K Parrish

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Baseline visual field characteristics in the ocular hypertension treatment study.

Racial differences in the cause-specific prevalence of blindness in east Baltimore.

Management of ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension

Number of people with glaucoma worldwide

Models of open-angle glaucoma prevalence and incidence in the United States.

Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice?

Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.

P304

276-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHTHALMOL.2010.20

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Chris A. Johnson

Michael A. Kass

J Philip Miller

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41825575

http://www.w3.org/2001/XMLSchema#string

P698

20212196

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3966140

http://www.w3.org/2001/XMLSchema#string